| Authors: |
Balbino B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Sorbonne Université, Paris, France., Herviou P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Godon O; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Stackowicz J; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Sorbonne Université, Paris, France., Goff OR; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Iannascoli B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Sterlin D; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière, Département d'Immunologie, Paris, France., Brûlé S; Plateforme de Biophysique Moléculaire, Institut Pasteur, UMR 3528 CNRS, Paris, France., Millot GA; Hub de Bioinformatique et Biostatistique, Département Biologie Computationnelle, Institut Pasteur, USR 3756 CNRS, Paris, France., Harris FM; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Voronina VA; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Nadeau KC; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA.; Division of Pulmonary and Critical Care, Department of Medicine, Stanford University, California, USA., Macdonald LE; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Murphy AJ; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Reber LL; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Center for Physiopathology of Toulouse-Purpan (CPTP), UMR 1043, University of Toulouse, INSERM CNRS, Toulouse France. |
